Month: January 2022

AllCells Announces First to Market Launch of In Stock GMP Cryopreserved Leukopaks

Collected from qualified healthy donors that meet baseline FDA 21 CFR 1271 requirements, industry’s first In Stock GMP Cryopreserved Leukopaks significantly decrease lead time   AllCells, the industry leader in the procurement and customization of human-derived hematological tissues and services, is pleased to announce the launch of its In Stock GMP Cryopreserved Leukopaks. While donor […]

Written by on January 28, 2022

FAQ Series: The Science Behind Cryopreservation

Primary cells, such as those isolated from the bone marrow or peripheral blood, are important for a wide scope of research and clinical applications – from studying molecular mechanisms driving disease progression, to developing ex vivo therapies in regenerative medicine. Unlike immortalized cell lines, primary cells have a finite lifespan in culture and can undergo unwanted changes like genetic drift and […]

Written by on January 11, 2022